Anavex Life Sciences
Price & Volume
Stats
See more52W Range | $3.51-$14.44 |
Market Cap | $791.9M |
Shares Short | 24M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.55 |
News
See moreYahoo Finance • 9 days ago
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board
Yahoo Finance • 11 days ago
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East
Yahoo Finance • 27 days ago
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
Yahoo Finance • last month
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference
About
CEO | Dr. Christopher U. Missling M.B.A., M.S., Ph.D. |
Address | 630 5th Avenue, New York, NY, United States, 10111 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 42 |
